Aggarwal, B. B., Kumar, A., & Bharti, A. C. (2003). Anticancer
potential of curcumin: Preclinical and clinical studies. Anticancer
Research, 23(1A), 363-398.
Bertram, J. S., Kolonel, L. N., & Meyskens, F. L. Jr. (1987).
Rationale and strategies for chemoprevention of cancer in
humans. Cancer Research, 47(11), 3012-3031.
Chen, D., & Dou, Q. P. (2008). Tea polyphenols and their roles in
cancer prevention and chemotherapy. International Journal of
Molecular Sciences, 9(7), 1196-1206.
Garikapaty, V. P., Ashok, B. T., Tadi, K., Mittelman, A., &
Tiwari, R. K. (2006). Synthetic dimer of indole-3-carbinol:
Second generation diet derived anti-cancer agent in hormone
sensitive prostate cancer. The Prostate, 66(5), 453-462.
Howells, L. M., Gallacher-Horley, B., Houghton, C. E., Manson,
M. M., & Hudson, E. A. (2002). Indole-3-carbinol inhibits protein
kinase B/Akt and induces apoptosis in the human breast tumor cell
line MDA MB468 but not in the nontumorigenic HBL100
line. Molecular Cancer Therapeutics, 1(13), 1161-1172.
Howells, L. M., & Manson, M. M. (2005). Prospects for plantderived
chemopreventive agents exhibiting multiple mechanisms
of action. Current Medicinal Chemistry. Anti-Cancer
Agents, 5(3), 201-213.
Howells, L. M., Moiseeva, E. P., Neal, C. P., Foreman, B. E.,
Andreadi, C. K., Sun, Y. Y., Manson, M. M. (2007). Predicting
the physiological relevance of in vitro cancer preventive activities
of phytochemicals. Acta Pharmacologica Sinica, 28(9), 1274-
1304.
Howells, L. M., Sale, S., Sriramareddy, S. N., Irving, G. R., Jones,
D. J., Ottley, C. J., Brown, K. (2011). Curcumin ameliorates
oxaliplatin-induced chemoresistance in HCT116 colorectal cancer
cells in vitro and in vivo. International Journal of Cancer, 129(2),
476-486.
Johnson, J. J., Syed, D.N., Heren, C. R., Suh, Y., Adhami, V. M.,
& Mukhtar, H. (2008). Carnosol, a dietary diterpene, displays
growth inhibitory effects in human prostate cancer PC3 cells
leading to G2-phase cell cycle arrest and targets the 5'-AMPactivated
protein kinase (AMPK) pathway. Pharmaceutical
Research, 25(9), 2125-2134.
Khan, N., & Mukhtar, H. (2008). Multitargeted therapy of cancer
by green tea polyphenols. Cancer Letters, 269(2), 269-280.
Kimura, K., Itakura, Y., Goto, R., Tojima, M., Egawa, N., &
Yoshihama, M. (2007). Inhibition of 17alpha-hydroxylase/C17,
20-lyase (CYP17) from rat testis by green tea catechins and black Biochemistry, 71(9), 2325-2328.
Lieberman, R., Bermejo, C., Akaza, H., Greenwald, P., Fair, W.,
& Thompson, I. (2001). Progress in prostate cancer
chemoprevention: Modulators of promotion and
progression. Urology, 58(6), 835-842.
Lin, L., Shi, Q., Nyarko, A. K., Bastow, K. F., Wu, C. C., Su, C.
Y., . . . Lee, K. H. (2006). Antitumor agents. 250. design and
synthesis of new curcumin analogues as potential anti-prostate
cancer agents. Journal of Medicinal Chemistry, 49(13), 3963-
3972.
Lippman, S. M., & Lee, J. J. (2006). Reducing the "risk" of
chemoprevention: Defining and targeting high risk--2005 AACR
cancer research and prevention foundation award lecture. Cancer
Research, 66(6), 2893-2903.
Manson, M. M., Foreman, B. E., Howells, L. M., & Moiseeva, E.
P. (2007). Determining the efficacy of dietary phytochemicals in
cancer prevention. Biochemical Society Transactions, 35(Pt 5),
1358-1363.
Maru, G. B., Hudlikar, R. R., Kumar, G., Gandhi, K., &
Mahimkar, M. B. (2016). Understanding the molecular
mechanisms of cancer prevention by dietary phytochemicals:
From experimental models to clinical trials. World Journal of
Biological Chemistry, 7(1), 88-99.
Montopoli, M., Ragazzi, E., Froldi, G., & Caparrotta, L. (2009).
Cell-cycle inhibition and apoptosis induced by curcumin and
cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell
Proliferation, 42(2), 195-206.
Nachshon-Kedmi, M., Yannai, S., Haj, A., & Fares, F. A. (2003).
Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in
human prostate cancer cells. Food and Chemical Toxicology: AnPaschka, A. G., Butler, R., & Young, C. Y. (1998). Induction of
apoptosis in prostate cancer cell lines by the green tea component,
(-)-epigallocatechin-3-gallate. Cancer Letters, 130(1-2), 1-7.
Pulido-Moran, M., Moreno-Fernandez, J., Ramirez-Tortosa, C., &
Ramirez-Tortosa, M. (2016). Curcumin and health. Molecules
(Basel, Switzerland), 21(3), E264.
Sarkar, F. H., & Li, Y. (2004). Cell signaling pathways altered by
natural chemopreventive agents. Mutation Research, 555(1-2),
53-64.
Shenouda, N. S., Zhou, C., Browning, J. D., Ansell, P. J., Sakla,
M. S., Lubahn, D. B., & Macdonald, R. S. (2004). Phytoestrogens
in common herbs regulate prostate cancer cell growth in
vitro. Nutrition and Cancer, 49(2), 200-208.
Singh, R. P., & Agarwal, R. (2006). Mechanisms of action of
novel agents for prostate cancer chemoprevention. Endocrine-
Related Cancer, 13(3), 751-778.
Thangapazham, R. L., Sharma, A., & Maheshwari, R. K. (2006).
Multiple molecular targets in cancer chemoprevention by
curcumin. The AAPS Journal, 8(3), E443-9.
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J.,
& Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer
Journal for Clinicians, 65(2), 87-108.
Valentini, A., Conforti, F., Crispini, A., De Martino, A., Condello,
R., Stellitano, C., Pucci, D. (2009). Synthesis, oxidant properties,
and antitumoral effects of a heteroleptic palladium (II) complex of
curcumin on human prostate cancer cells. Journal of Medicinal
Chemistry, 52(2), 484-491.